Adragos Hub

De-Risking Sterile Fill-Finish from Clinical to Commercial How expanded CDMO capabilities, lyophilisation expertise and a flexible facility network help accelerate sterile product success. Sterile product development and manufacturing can be complex. Scale-up, lyophilisation, technology transfer, quality expectations and supply continuity […]

Choosing the right sterile injectable CDMO is one of the highest stakes decisions a pharmaceutical or biotech team will make, and a rigorous audit is how you reduce the risk. A sterile injectable CDMO audit examines fill-finish operations, quality systems, […]

Selecting a Contract Development and Manufacturing Organisation for small molecule formulation and High-Potency Active Pharmaceutical Ingredient handling is one of the most consequential decisions a pharma or biotech team will make. Choosing the right small molecule HPAPI CDMO shortens timelines, […]

Scaling semi-solid and liquid pharmaceutical products from development batches to commercial volumes requires a disciplined sequence of technology transfer, equipment qualification and process validation activities. For creams, ointments, gels, suspensions, solutions and syrups, the rheological behaviour, homogeneity and microbiological control […]

Scaling Semisolids & Liquids in Pharma | Adragos Scaling semisolid and liquid pharmaceutical products from laboratory to commercial manufacturing requires a systematic progression through formulation development, pilot batch production, process validation and technology transfer. Each stage introduces new critical process […]

Process validation is what turns a promising semi-solid or liquid formulation into a product that can be made reliably at commercial scale. This guide explains what process validation in pharma scale-up is, the three regulatory stages it follows, why scale-up […]